Cleared Traditional

K202839 - Overlapped Compression Therapy

K202839 is an FDA 510(k) clearance for Overlapped Compression Therapy, manufactured by Jkh Health Co., Ltd.. The device is a Class 2 Cardiovascular device with product code JOW cleared through the Traditional 510(k) pathway after a 118-day FDA review.

K202839 · Jkh Health Co., Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2021
Decision
118d
Days
Class 2
Risk

K202839 is an FDA 510(k) clearance for the Overlapped Compression Therapy. Classified as Sleeve, Limb, Compressible (product code JOW), Class II - Special Controls.

Submitted by Jkh Health Co., Ltd. (Shenzhen, CN). The FDA issued a Cleared decision on January 21, 2021 after a review of 118 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.5800 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Jkh Health Co., Ltd. devices

FDA 510(k) Submission Details - K202839

510(k) Number K202839 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 25, 2020
Decision Date January 21, 2021
Days to Decision 118 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
7d faster than avg
Panel avg: 125d · This submission: 118d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JOW Device Classification - Class 2, Special Controls

Product Code JOW Sleeve, Limb, Compressible
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.5800
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - JOW Sleeve, Limb, Compressible

All 120
Devices cleared under the same product code (JOW) and FDA review panel - the closest regulatory comparables to K202839.
DVT-4000S
K203417 · Daesung Maref Co., Ltd. · Mar 2021
Movement and Compressions System (the MAC System)
K203052 · Recovery Force, LLC · Mar 2021
Ezlymph, Ezlymph M
K193662 · Eezcare Medical Corp · Feb 2021
Flexitouch Plus System
K203178 · Tactile Systems Technology, Inc. (Dba Tactile Medical) · Dec 2020
DVT-2600
K203016 · Daesung Maref Co., Ltd. · Dec 2020
B&J DVT Calf/Thigh Garments, Models 801/830 Series
K201532 · B&J Manufacturing , Ltd. · Sep 2020